Why the study?
Childhood hypertension is underrecognized and underdiagnosed despite increasing adult cardiovascular disease risk, and updated European and American guidelines contain notable differences alongside similarities.
Answers are grounded in this paper and cite their sources.
The review highlights key differences and similarities between the 2016 ESH and 2017 AAP guidelines for managing pediatric hypertension.
Childhood hypertension (HTN) has become a significant public health issue because of the increased risk of cardiovascular disease in adulthood. However, childhood HTN is underrecognized and underdiagnosed in clinical practice. The European Society of Hypertension in 2016 and the American Academy of Pediatrics (AAP) in 2017 published updated guidelines for the screening, prevention, and management of pediatric HTN. There were notable differences between the two guidelines as well as many similarities. The updated AAP guidelines have clarified and simplified the recommendations for screening, diagnosis, and treatment of childhood HTN based on current evidence. This review highlights the important developments in both guidelines, focusing on recent advances in the classification and treatment of childhood HTN.
No takes yet. Share an insight, caveat, or question.
Park et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: